Business Description
ISIN : US30260D1037
Share Class Description:
FIGS: Class ATotal Employee Number:
388Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.14 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.73 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 12.44 | |||||
Beneish M-Score | -1.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.2 | |||||
3-Year EBITDA Growth Rate | 7.6 | |||||
3-Year EPS without NRI Growth Rate | 5.9 | |||||
3-Year Book Growth Rate | 12.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 30.92 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.38 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.02 | |||||
9-Day RSI | 37.43 | |||||
14-Day RSI | 47.22 | |||||
3-1 Month Momentum % | 23.14 | |||||
6-1 Month Momentum % | -13.15 | |||||
12-1 Month Momentum % | 108.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.96 | |||||
Quick Ratio | 3.65 | |||||
Cash Ratio | 3.24 | |||||
Days Inventory | 222.73 | |||||
Days Sales Outstanding | 3.63 | |||||
Days Payable | 19.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 1.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.91 | |||||
Operating Margin % | 9.6 | |||||
Net Margin % | 8.72 | |||||
EBITDA Margin % | 11.11 | |||||
FCF Margin % | 13.69 | |||||
OCF Margin % | 15.21 | |||||
ROE % | 14.6 | |||||
ROA % | 11.1 | |||||
ROIC % | 23.02 | |||||
3-Year ROIIC % | 14.3 | |||||
ROC (Joel Greenblatt) % | 41.54 | |||||
ROCE % | 14.44 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 41.24 | |||||
Forward PE Ratio | 34.9 | |||||
PE Ratio without NRI | 41.24 | |||||
Price-to-Owner-Earnings | 39.92 | |||||
PS Ratio | 3.65 | |||||
PB Ratio | 5.1 | |||||
Price-to-Tangible-Book | 5.1 | |||||
Price-to-Free-Cash-Flow | 26.84 | |||||
Price-to-Operating-Cash-Flow | 24.14 | |||||
EV-to-EBIT | 29.66 | |||||
EV-to-Forward-EBIT | 22.26 | |||||
EV-to-EBITDA | 25.65 | |||||
EV-to-Forward-EBITDA | 20.06 | |||||
EV-to-Revenue | 2.85 | |||||
EV-to-Forward-Revenue | 2.55 | |||||
EV-to-FCF | 20.8 | |||||
Price-to-GF-Value | 1.77 | |||||
Price-to-Projected-FCF | 2.96 | |||||
Price-to-Peter-Lynch-Fair-Value | 2 | |||||
Price-to-Graham-Number | 3.06 | |||||
| Price-to-Net-Current-Asset-Value | 7.2 | |||||
| Price-to-Net-Cash | 14.48 | |||||
Earnings Yield (Greenblatt) % | 3.37 | |||||
FCF Yield % | 4.3 | |||||
Forward Rate of Return (Yacktman) % | 21.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:FIGS
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
FIGS Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 710.078 | ||
| EPS (TTM) ($) | 0.33 | ||
| Beta | 0.4735 | ||
| 3-Year Sharpe Ratio | 0.71 | ||
| 3-Year Sortino Ratio | 1.5 | ||
| Volatility % | 73.38 | ||
| 14-Day RSI | 47.22 | ||
| 14-Day ATR ($) | 0.683785 | ||
| 20-Day SMA ($) | 14.7405 | ||
| 12-1 Month Momentum % | 108.78 | ||
| 52-Week Range ($) | 6.5 - 17.48 | ||
| Shares Outstanding (Mil) | 166.14 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FIGS Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FIGS Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-26 17:00 | In 171 days | ||
| Annual report for 2026 | 2027-02-26 | In 170 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 170 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 17:00 | In 59 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 58 days | ||
| Barclays 19th Annual Global Consumer Conference | 2026-09-08 12:00 | 14.42 (-3.03%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 17:00 | 10.92 (+1.16%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 10.92 (+1.16%) | ||
| Guidance call for 2026 | 2026-06-09 12:00 | 11.58 (-3.74%) | ||
| General meeting for 2026 | 2026-06-03 13:30 | 11.43 (-1.47%) |
FIGS Inc Frequently Asked Questions
Guru Commentaries on NYSE:FIGS
FIGS, Inc. designs and sells scrubwear for health care professionals through a digitally native, direct-to-consumer strategy. The company reported a very strong first quarter, with revenue of $159.9 million, up 28%, significantly exceeding guidance for low-20% growth and consensus expectations. U.S. revenue grew 24% to $131.6 million, driven by strength across core offerings, new product launches, and promotional periods. International revenue accelerated 50% to $28.3 million, with double-digit growth in every region. Active customers surpassed 3 million for the first time, up 12% year over year, indicating strong market share gains in the attractive global health care apparel industry.
FIGS, Inc. designs and sells scrubwear for health care professionals through a digitally native, direct-to-consumer strategy.
FIGS, Inc. designs and sells scrubwear for health care professionals through a digitally native, direct-to-consumer strategy. Shares rose following robust fourth-quarter results and upbeat 2026 guidance. Revenue expanded 33% to $201.9 million, reflecting broad-based momentum across categories and geographies and exceeding expectations. U.S. revenue rose 28.7% to $164.2 million, while international revenue accelerated 55% to $37.7 million. This topline strength translated to profitability, with EBITDA rising 29.8% to $26.7 million. The company maintains a strong balance sheet, with no debt and roughly $300 million in cash and marketable securities.
FIGS, Inc. designs and sells scrubwear for health care professionals through a digitally native, direct-to-consumer strategy. Shares rose following robust fourth-quarter results and upbeat 2026 guidance. Revenue expanded 33% to $201.9 million, reflecting broad-based momentum across categories and geographies and exceeding expectations. U.S. revenue rose 28.7% to $164.2 million, while international revenue accelerated 55%. The company maintains a strong balance sheet, with no debt and roughly $300 million in cash and marketable securities, positioning it well for future growth.
Shares of FIGS increased 18.6% in the quarter and added 35 bps to performance. The company is generating strong results and accelerating revenue from recent investments made over the past year. This is despite making a conscious decision to pull back on promotions. After several years of industry pressure, FIGS is now seeing more normal purchasing and replenishment patterns while also benefiting from specific initiatives around product and marketing that are resonating with its customers. The company is also seeing better-than-expected margin improvements as they begin to get better efficiency out of their new fulfillment center. We continue to believe FIGS can take share in the attractive $80 billion global health care apparel industry.
FIGS, Inc. designs and sells scrubwear for health care professionals using a digitally native, direct-to-consumer strategy. Shares rose after the company reported better-than-expected quarterly results and raised its revenue and profitability guidance for the remainder of the year. Despite intentionally reducing promotional activity, FIGS achieved nearly 6% revenue growth during the second quarter and delivered stronger-than-expected margin improvement driven by efficiency gains at its new fulfillment center. Looking ahead, we retain conviction in FIGS’ ability to gain share given its high-quality, needs-based products and exposure to the fast-growing U.S. health care industry.
